Market: NMS |
Currency:
Address:
📈 CV Historical Chart
📊 Statistics
-
Analyst 1 Year Price Target:
$10.50
-
Upside/Downside from Analyst Target:
75.00%
-
Broker Call:
4
-
Dividend Minimum 3 Year Yield:
0.00%
-
EPS Growth Range (1Y):
-
-
Net Income Growth Range (1Y):
-
-
Revenue Growth Range (1Y):
-
-
Upcoming Earnings Date:
-
💰 Dividend History
No dividend history available.
📅 Earnings & EPS History for CV
No earnings history available for this symbol.
📰 Related News & Research
-
CVB Financial Corp. Receives Regulatory Approvals for Merger with Heritage Commerce Corp., Closing Expected April 17, 2026
April 2, 2026
CVB Financial Corp. Receives Regulatory Approvals for Merger...
-
CVB Financial Corp and Heritage Commerce Corp Shareholders Approve Merger, Anticipated Completion in Q2 2026
March 28, 2026
CVB Financial Corp and Heritage Commerce Corp Shareholders A...
-
CVB Financial Corp and Heritage Commerce Corp Shareholders Approve Proposed Merger, Closing Expected Q2 2026
March 28, 2026
CVB Financial Corp. and Heritage Commerce Corp. Shareholders...
-
CV Sciences, Inc. 2025 Business Overview: Leading Hemp Extracts, Plant-Based Foods, and CBD Products Company
March 27, 2026
CV Sciences, Inc. 2025 Annual Report – Key Investor Insights...
-
CVD Equipment Corp Sells SDC Division to Atlas Copco for $16.9 Million to Focus on Core Business 1
March 24, 2026
CVD Equipment Corporation Announces Sale of SDC Division to ...
-
Pyxis Oncology Reports 2025 Financial Results, Advances MICVO Cancer Trials, and Announces New Leadership
March 23, 2026
Pyxis Oncology Reports Q4 and Full-Year 2025 Results, Provid...
-
MicuRx Pharmaceuticals: Advancing Novel ADC Therapy MICVO for Difficult-to-Treat Head and Neck Cancer – Pipeline, Strategy, and Risks Overview
March 23, 2026
Pyxis Oncology 2025 Annual Report: Key Highlights for Invest...
-
CVR Partners, LP Files Form 8-K for Amendment to Limited Partnership Agreement (March 17, 2026)
March 19, 2026
CVR Partners, LP Announces Key Board Appointment and Partner...
-
CVB Financial Corp. (CVBF) 2025 Financial Performance, Key Metrics, and Industry Comparison
March 18, 2026
CVB Financial Corp. Issues Important Supplemental Disclosure...
-
CV Sciences Announces Debt Restructuring and Launches New Plant-Based Wellness Products to Drive Growth
March 11, 2026
CV Sciences Announces Major Debt Restructuring and Product L...
🔍 View more Reports